sec filing
XF
NASDAQ · XFOR
X4 Pharmaceuticals, Inc.
Healthcare · Biotechnology
$2.45
Down-$0.15 (-5.77%)
Updated Oct 15, 2026, 4:52 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 44.21M
- P/E ratio
- -0.28
- Dividend yield
- 0.00%
- 52-week range
- $2.43 – $4.83
- Volume
- 705.74K
- Avg. volume
- 894.59K
Price performance · XFOR
XFOR price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 14, 2026
XFOR closed at $2.45 after 21 trading sessions, down 30.20% for the selected period.
- Last close
- $2.45
- Period change
- -30.20%
- Period low
- $2.45
- Period high
- $3.58
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | $2.54 | $2.55 | $2.43 | $2.45 | 705.74K |
| Oct 13, 2026 | $2.81 | $2.83 | $2.59 | $2.60 | 439.6K |
| Oct 12, 2026 | $2.89 | $2.93 | $2.81 | $2.82 | 404.69K |
| Oct 9, 2026 | $2.83 | $2.965 | $2.815 | $2.91 | 541.23K |
| Oct 8, 2026 | $2.77 | $2.81 | $2.70 | $2.79 | 836.5K |
| Oct 7, 2026 | $2.74 | $2.86 | $2.70 | $2.81 | 435.38K |
| Oct 6, 2026 | $2.90 | $2.90 | $2.70 | $2.77 | 642.47K |
| Oct 5, 2026 | $2.88 | $2.935 | $2.73 | $2.90 | 698.1K |
| Oct 2, 2026 | $2.86 | $2.86 | $2.745 | $2.83 | 911.4K |
| Oct 1, 2026 | $2.89 | $2.95 | $2.82 | $2.83 | 501.49K |
| Sep 30, 2026 | $2.93 | $2.935 | $2.845 | $2.90 | 1.76M |
| Sep 29, 2026 | $3.01 | $3.055 | $2.895 | $2.90 | 1.71M |
| Sep 28, 2026 | $2.996 | $3.04 | $2.81 | $3.015 | 838.4K |
| Sep 25, 2026 | $2.98 | $3.0834 | $2.965 | $3.01 | 1.86M |
| Sep 24, 2026 | $3.10 | $3.10 | $2.955 | $3.00 | 973.68K |
| Sep 23, 2026 | $3.41 | $3.42 | $3.035 | $3.11 | 2.31M |
| Sep 22, 2026 | $3.52 | $3.57 | $3.40 | $3.43 | 923.76K |
| Sep 21, 2026 | $3.58 | $3.58 | $3.455 | $3.495 | 444.36K |
| Sep 18, 2026 | $3.48 | $3.635 | $3.48 | $3.58 | 1.54M |
| Sep 17, 2026 | $3.56 | $3.585 | $3.41 | $3.50 | 635.05K |
| Sep 16, 2026 | $3.63 | $3.65 | $3.355 | $3.51 | 973.34K |
Latest XFOR news
The latest Smart Investors Daily articles mentioning XFOR.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

